Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Computational Medicine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.0% during the forecast period.
This report presents the market size and development trends by detailing the Computational Medicine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Computational Medicine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Computational Medicine industry and will help you to build a panoramic view of the industrial development.
Computational Medicine Market, By Type:
Type 1
Type 2
Type 3
Computational Medicine Market, By Application:
End-User 1
End-User 2
End-User 3
Some of the leading players are as follows:
Dassault Systemes, BIOVIA Corp.
Domainex Ltd
Collaborative Drug Discovery, Inc.
Compugen Ltd
Certara, L.P.
Certara, LP.
Chemical Computing Group Inc.
Crown Bioscience Inc.
Aurora Fine Chemicals LLC
Biognos AB
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Computational Medicine Market: Technology Type Analysis
-
4.1 Computational Medicine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Computational Medicine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Type 1
4.3.2 Type 2
4.3.3 Type 3
5 Computational Medicine Market: Product Analysis
-
5.1 Computational Medicine Product Market Share Analysis, 2018 & 2026
-
5.2 Computational Medicine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Computational Medicine Market: Application Analysis
-
6.1 Computational Medicine Application Market Share Analysis, 2018 & 2026
-
6.2 Computational Medicine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 End-User 1
6.3.2 End-User 1
6.3.3 End-User 3
7 Computational Medicine Market: Regional Analysis
-
7.1 Computational Medicine Regional Market Share Analysis, 2018 & 2026
-
7.2 Computational Medicine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Dassault Systemes, BIOVIA Corp.
9.1.1 Dassault Systemes, BIOVIA Corp. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Domainex Ltd
9.2.1 Domainex Ltd Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Collaborative Drug Discovery, Inc.
9.3.1 Collaborative Drug Discovery, Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Compugen Ltd
9.4.1 Compugen Ltd Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Certara, L.P.
9.5.1 Certara, L.P. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Certara, LP.
9.6.1 Certara, LP. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Chemical Computing Group Inc.
9.7.1 Chemical Computing Group Inc. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Crown Bioscience Inc.
9.8.1 Crown Bioscience Inc. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Aurora Fine Chemicals LLC
9.9.1 Aurora Fine Chemicals LLC Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Biognos AB
9.10.1 Biognos AB Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 73 Figures and 125 Tables)
Figure Type 1 Computational Medicine market, 2015 - 2026 (USD Million)
Figure Type 2 Computational Medicine market, 2015 - 2026 (USD Million)
Figure Type 3 Computational Medicine market, 2015 - 2026 (USD Million)
Figure End-User 1 market, 2015 - 2026 (USD Million)
Figure End-User 2 market, 2015 - 2026 (USD Million)
Figure End-User 3 market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Computational Medicine market, by country, 2015 - 2026 (USD Million)
-
Table North America Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table North America Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table North America Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Computational Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table France Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table France Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Computational Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table China Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table China Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table India Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table India Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Computational Medicine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Computational Medicine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Computational Medicine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Computational Medicine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Computational Medicine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Dassault Systemes, BIOVIA Corp. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Domainex Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Collaborative Drug Discovery, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Compugen Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Certara, L.P. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Certara, LP. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Chemical Computing Group Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Crown Bioscience Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aurora Fine Chemicals LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biognos AB Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
